Elusys Therapeutics
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis (NCT03088111) | Elusys Therapeutics | 2023-12-01 |
Track Elusys Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.